Assessing Dysmorphic Facial Features associated with Prenatal Alcohol Exposure
Welcome to Assessing Dysmorphic Facial Features associated with Prenatal Alcohol Exposure!
This course focuses on the assessment of the physical features associated with Fetal Alcohol Spectrum Disorders (FASD). The potential effects of prenatal alcohol exposure are wide-ranging, and not all affected children have distinguishing facial features. However, for those who do, recognition of these features is a powerful diagnostic tool that can provide confirmation of prenatal exposure to alcohol as well as diagnostic clarity.
There is normal variation of the cardinal facial features depending in part on family or racial background. Comparison with other family members who were NOT exposed to alcohol before birth, when available, and use of race-specific lip-philtrum guides, can help account for this variation.
Fetal alcohol spectrum disorders (FASD) affects 1/20 children surpassing Autism Spectrum Disorder. While early diagnosis improves outcomes, many children go undiagnosed into adolescence or adulthood. Our goal with this course is to increase diagnostic capacity by pediatric clinicians.
Target audience includes physicians, nurses, and other clinicians who may treat/work with children with FASD and their families, with a focus on pediatric clinicians.
One outcome we hope to see is for pediatricians and pediatric nurse practitioners to increase their comfort and willingness to assess children for physical features that might be effects of prenatal exposure to alcohol.
These features themselves are often neither highly distinguishing nor problematic but can help to clarify the cause of developmental and behavioral problems a child may be experiencing and provide guidance to informed and evidence-based interventions.
At the end of the activity, learners will be able to:
- List the characteristic dysmorphic features associated with some fetal alcohol spectrum disorders (FASDs).
- Recognize and assess dysmorphic features that should be evaluated when considering any of the FASD diagnoses.
|David Wargowski, MD|
Course Director, Planner, Content Developer, Reviewer
|Angelica Salinas, MS|
Planner, Content Developer, Reviewer
|Georgiana Wilton, PhD|
Planner, Content Developer, Reviewer
|Jacquelyn Bertrand, PhD|
|Prachi Shah, MD|
|Natasha Singh, MPA|
|Erin Tenney, NP|
|Julie Martinelli, BS|
UW-Madison ICEP Staff
|Jessica Carlucci-Jenkins, BA|
UW-Madison ICEP Staff
It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during the educational activity. For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:
David Wargowski, MD has no relevant relationships to disclose in regard to this activity.
Angelica Salinas, MS has no relevant relationships to disclose in regard to this activity.
Georgiana Wilton, PhD has no relevant relationships to disclose in regard to this activity.
Jacquelyn Bertrand, PhD has no relevant relationships to disclose in regard to this activity.
Prachi Shah, MD has no relevant relationships to disclose in regard to this activity.
Natasha Singh, MPA has no relevant relationships to disclose in regard to this activity.
Erin Tenney, NP has no relevant relationships to disclose in regard to this activity.
Jessica Carlucci-Jenkins, BA has no relevant relationships to disclose in regard to this activity.
Julie Martinelli, BS has no relevant relationships to disclose in regard to this activity.
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Disclosure of Unlabeled Use: The University of Wisconsin–Madison ICEP advises the participant that this continuing medical education activity does NOT contain reference(s) to unlabeled or unapproved uses of drugs or devices
REVIEWED ON 8/3/2020
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hours. The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .1 continuing education units (CEUs) or 1 hours.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
Free, current version of Internet Explorer, Firefox, Safari, or Chrome. Some older browsers and Microsoft Edge could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader